Researchers have discovered that the structure of human bones is vastly different than previously believed — findings which will have implications for how some debilitating bone disorders are treated.
Cornell University engineers say they have developed a microvascular system that can nourish growing tissues, a step that may one day allow laboratories to grow synthetically engineered tissues for transplants.
Eating fewer refined carbohydrates may slow the progression of age-related macular degeneration (AMD), according to a new study from researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University.
Researchers are now one step closer to improved treatment of Type 2 diabetes following significant findings made by scientists at the Garvan Institute of Medical Research.
Even relatively low doses of resveratrol—a chemical found in the skins of red grapes and in red wine—can improve the sensitivity of mice to the hormone insulin, according to a report in the October issue of Cell Metabolism, a Cell Press publication.
A glitch in the production and folding of molecules deep within the insulin-producing cells of the pancreas may be responsible for the death of those cells and the onset of diabetes, new animal research suggests.
Asam Urat Flu Tulang, PJ Dewandaru is a health product promoted to treat joint pain, rheumatism and arthritis. Health Canada is advising consumers not to use the product due to concerns about possible side-effects.
Khun-Phra is a health product promoted to treat arthritis and joint pain. Health Canada is advising consumers not to use the product due to concerns about possible side-effects.
Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient’s quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of The Lancet.
Many patients with diabetes say that the inconvenience and discomfort of constant therapeutic vigilance, particularly multiple daily insulin injections, has as much impact on their quality of life as the burden of intermediate complications, researchers from the University of Chicago report in the October 2007 issue of Diabetes Care.